πŸ‡ΊπŸ‡Έ FDA
Patent

US 8394803

Gyrase inhibitors and uses thereof

granted A61PA61P31/04A61P43/00

Quick answer

US patent 8394803 (Gyrase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P31/04, A61P43/00